Dr. Paul Chapman: Exciting Times Ahead—Things Are Changing Very Quickly in Melanoma Research
Dr. Paul Chapman: Exciting Times Ahead—Things Are Changing Very Quickly in Melanoma Research
Interview by L Scott Zoeller
20110508
2011 Jun 8
OncologySTAT Editorial Team
Dr. Paul Chapman: Exciting Times Ahead—Things Are Changing Very Quickly in Melanoma Research
OncologySTAT Editorial Team. 2011 Jun 8, Interview by L Scott Zoeller
Paul B. Chapman, MD, is Head of the Melanoma Section Clinical Immunology Service Department of Medicine, Memorial Sloan-Kettering Cancer Center. Original interview from February 2011; Updated on June 8, 2011OncologySTAT: Dr. Chapman, you have been involved in groundbreaking research in the field of metastatic melanoma. Would you discuss the underlying mechanisms of advanced disease, the results of your research on BRAF inhibition, and the potential for development of novel targeted therapy?Dr. Chapman:...
Meet Our Experts
Meet our Advisory and Editorial Boards comprised of physician editors and world-renowned experts.
